Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,317
Total Claims
$901K
Drug Cost
720
Beneficiaries
$1,251
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-66%
Opioid rate vs peers
1.0% vs 3.0% avg
+193%
Cost per patient vs peers
$1,251 vs $427 avg
+115%
Brand preference vs peers
11.3% vs 5.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.0%
Opioid Rate
178
Opioid Claims
$4,040
Opioid Cost
7.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,946 claims · $595K
Generic: 15,323 claims · $303K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 416 | $175K |
| Rivaroxaban | 70 | $35K |
| Dulaglutide | 32 | $31K |
| Sitagliptin Phosphate | 68 | $30K |
| Rifaximin | 17 | $27K |
| Fluticasone/Vilanterol | 35 | $17K |
| Mirabegron | 33 | $15K |
| Fluticasone Propion/Salmeterol | 30 | $14K |
| Empagliflozin | 31 | $13K |
| Atorvastatin Calcium | 1,029 | $12K |
| Carbidopa | 11 | $12K |
| Insulin Aspart | 26 | $8,915 |
| Umeclidinium Brm/Vilanterol Tr | 18 | $8,876 |
| Umeclidinium Bromide | 23 | $8,744 |
| Insulin Aspart | 27 | $8,330 |
Prescribing Profile
Patient Profile
82
Avg Age
67%
Female
2.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About